Berkeley Lights, Inc. (BLI), a digital company related to the field of cell biology, has gained an increase of 1.74 percentage points, and hence, was trading at $6.42 when last checked. During Wednesday’s regular trading session, the stock rose by 6.41% to close the day at $6.31. The stock is on the rise owing to a new appointment in the executive setup of the company.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Appointment of CEO
On Wednesday, BLI announced the appointment of Dr. Siddhartha Kadia in the role of CEO of the company. Before Dr. Kadia, Eric D. Hobbs, Ph.D. was serving as the Chief Executive Officer of the company. Dr. Kadia has experience of more than 2 decades in leadership positions. Alongside, his expertise also encompasses life sciences technologies and services. Before joining Berkeley, he was serving as president and CEO of EAG Laboratories.
Participation in Festival of Biologics Meeting
On the 4th of March, BLI reported that it would be participating in the Festival of Biologics meeting. The meeting was to be held from 9th of March to 11th of March, 2022. The festival is aimed at bringing together numerous institutes from the biotech industry, pharma industry, research institutes, and Academia as well as other ones in the area of immunotherapy, antibodies, etc. At the festival, Berkeley would show the Berkeley Lights Platform and single B-cell antibody discovery workflow.
BLI Released Upgrade to Software Suite
On the 3rd of March, BLI released an upgrade to its Software Suite. The upgrade included the enhancement in Cell Analysis Suite, Assay Analyzer and Image Analyzer meant for the Berkeley Lights Beacon and Lightning Systems. The company said that the installation of new features would serve the purpose of delivering easier insights, faster throughput operations for cell line development and cell therapy workflows.
What’s Next for BLI?
According to analysts, BLI stock holds a negative evaluation, as the technical indicators are pointing towards a bleak future for the stock in the next few weeks. Investors should take careful decisions keeping in mind this forecast.
